Steris PLC STE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if STE is a good fit for your portfolio.
News
-
PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP
-
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
-
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
-
STERIS Announces Dividend of $0.52 per share
-
STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
-
Becton Dickinson Divests Surgical Instrumentation Segment to Steris for $540 Million
-
Steris paying $540 mln for BD surgical instrument unit
Trading Information
- Previous Close Price
- $199.01
- Day Range
- $197.82–201.67
- 52-Week Range
- $180.54–254.00
- Bid/Ask
- $196.90 / $203.55
- Market Cap
- $19.79 Bil
- Volume/Avg
- 1.1 Mil / 480,174
Key Statistics
- Price/Earnings (Normalized)
- 23.28
- Price/Sales
- 3.67
- Dividend Yield (Trailing)
- 1.02%
- Dividend Yield (Forward)
- 1.05%
- Total Yield
- 1.86%
Company Profile
Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 17,100
- Website
- https://www.steris-ir.com
Comparables
Valuation
|
Metric
|
STE
|
CTEC
|
TSTL
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.28 | 24.57 | 34.94 |
Price/Book Value | 3.07 | 4.41 | 7.16 |
Price/Sales | 3.67 | 3.40 | 5.69 |
Price/Cash Flow | 18.47 | 19.52 | 22.21 |
Price/Earnings
STE
CTEC
TSTL
Financial Strength
|
Metric
|
STE
|
CTEC
|
TSTL
|
|---|---|---|---|
Quick Ratio | 1.27 | 0.79 | 3.93 |
Current Ratio | 2.43 | 1.62 | 4.92 |
Interest Coverage | 5.89 | 3.21 | 41.17 |
Quick Ratio
STE
CTEC
TSTL
Profitability
|
Metric
|
STE
|
CTEC
|
TSTL
|
|---|---|---|---|
Return on Assets (Normalized) | 7.72% | 7.44% | 17.36% |
Return on Equity (Normalized) | 13.77% | 16.69% | 23.20% |
Return on Invested Capital (Normalized) | 10.08% | 10.90% | 19.60% |
Return on Assets
STE
CTEC
TSTL
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Jljcxkd | Wdsdqr | $183.8 Bil | |
SYK
| Stryker Corp | Ppvgtqdby | Gfrqr | $127.8 Bil | |
MDT
| Medtronic PLC | Brdfmcqg | Ltmzmm | $105.0 Bil | |
BSX
| Boston Scientific Corp | Gpnkhyc | Bmmvkl | $99.9 Bil | |
EW
| Edwards Lifesciences Corp | Lpvnkcqmj | Mmzkh | $52.5 Bil | |
DXCM
| DexCom Inc | Dbpkbrqwj | Dxvqr | $51.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Wfvqzqbqg | Sjzr | $24.9 Bil | |
ALGN
| Align Technology Inc | Jcjklqzl | Lkxjg | $22.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Tgzpgfcy | Kmvtv | $18.5 Bil | |
PODD
| Insulet Corp | Rmntbndjc | Bxktjpr | $11.6 Bil |